Skip to main content

Table 2 Multiple logistic regression analyses for independent risk factors of NOAF

From: Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction

 

Estimated β

OR (95% CI)

P value

Model 1

   

 Age, years

0.12

1.127 (1.063–1.196)

P < 0.001

 Hs-CRP, mg/L

0.034

1.034 (1.018–1.05)

P < 0.001

 BNP, pg/ml

0.001

1 (0.999–1.001)

0.446

Model 2

   

 Age, years

0.118

1.125 (1.036–1.221)

0.005

 Hs-CRP, mg/L

0.026

1.026 (1.01–1.048)

0.013

 LAD, mm

0.055

1.057 (0.921–1.213)

0.43

 LVEF, %

− 0.018

0.983 (0.932–1.036)

0.516

Model 3

   

 Hs-CRP, mg/L

0.028

1.028 (1.016–1.04)

P < 0.001

 CHADS2 score

0.338

1.403 (1.025–1.92)

0.035

Model 4

   

 Hs-CRP, mg/L

0.028

1.028 (1.015–1.041)

P < 0.001

 CHA2DS2-VASc score

0.425

1.529 (1.173–1.994)

0.002

  1. Variables included in model 1 are age, hs-CRP and BNP. Variables included in model 2 are age, hs-CRP, LAD and LVEF. Variables included in model 3 are hs-CRP and the CHADS2 score. Variables included in model 4 are hs-CRP and the CHA2DS2-VASc score
  2. NOAF, new-onset atrial fibrillation; Hs-CRP, high sensitive c-reactive protein; BNP, B-type natriuretic peptide; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LAD, left atrium diameter; LVEF, left ventricular ejection fraction;
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us